Supported by a research grant from Boston Scientific to the University of Rochester, with funds distributed to the coordination and data center, enrolling centers, core laboratories, committees, and boards under subcontracts from the University of Rochester. Katia Noyes was in part supported by the Clinical and Translational Science Award (UL1 RR024160) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research.
Cost-Effectiveness of Cardiac Resynchronization Therapy in the MADIT-CRT Trial
Article first published online: 22 AUG 2012
© 2012 Wiley Periodicals, Inc.
Journal of Cardiovascular Electrophysiology
Volume 24, Issue 1, pages 66–74, January 2013
How to Cite
NOYES, K., VEAZIE, P., HALL, W. J., ZHAO, H., BUTTACCIO, A., THEVENET-MORRISON, K. and MOSS, A. J. (2013), Cost-Effectiveness of Cardiac Resynchronization Therapy in the MADIT-CRT Trial. Journal of Cardiovascular Electrophysiology, 24: 66–74. doi: 10.1111/j.1540-8167.2012.02413.x
- Issue published online: 2 JAN 2013
- Article first published online: 22 AUG 2012
- Manuscript received 15 May 2012; Revised manuscript received 15 Jun 2012; Accepted for publication 3 July 2012.
(A) Further information on cost methods.
(B) Supporting data for Figures 2 and 3.
Table S1: Cost Effectiveness by Years in LBBB Patients
Table S2: Cost Effectiveness in Sex and Age Subgroups of the LBBB Patient Group
|JCE_2413_sm_suppmat.doc||130K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.